

Overview
Gluten-related disorders, commonly underdiagnosed in India, encompass a spectrum of immune-mediated and non-immune conditions triggered by wheat and gluten ingestion, most prominently celiac disease (CD) and non-celiac wheat sensitivity (NCWS). Celiac disease is a systemic autoimmune disorder occurring in genetically susceptible individuals, characterized by small intestinal enteropathy and a broad range of gastrointestinal and extra-intestinal manifestations. In contrast, non-celiac wheat sensitivity, traditionally known as non-celiac gluten sensitivity (NCGS), is defined by gluten-related symptoms in the absence of celiac-specific serology or villous atrophy, with mechanisms that remain incompletely understood.
Epidemiologically, celiac disease affects individuals across all age groups and ethnicities, with many patients presenting with non-classical or extra-intestinal features rather than overt malabsorption. In contrast, non-celiac wheat sensitivity are frequently self-identified conditions, with prevalence estimates varying widely due to the absence of validated biomarkers. Many individuals initiate a gluten-free diet prior to formal evaluation, complicating diagnostic accuracy and clinical interpretation.
Accurate celiac disease diagnosis relies on serologic testing, including tissue transglutaminase antibodies, supported by histologic confirmation while the patient is consuming a gluten-containing diet. Genetic testing for HLA-DQ2/DQ8 may assist in exclusion but is not diagnostic in isolation. Non-celiac gluten sensitivity, on the other hand, requires careful exclusion of celiac disease and IgE-mediated wheat allergy, as well as evaluation of symptom reproducibility following gluten or wheat exposure.
Untreated celiac disease is associated with clinically significant complications, including persistent villous atrophy, micronutrient deficiencies, osteoporosis, and increased risk of lymphoproliferative malignancy. These risks are not observed in non-celiac wheat sensitivity, underscoring the importance of precise differentiation and risk stratification in clinical practice.
Long-term celiac disease management centers on strict lifelong adherence to a gluten-free diet, monitoring of serologic markers, nutritional optimization, and surveillance for complications. In contrast, dietary approaches in non-celiac gluten sensitivity are individualized, often focusing on symptom-directed gluten or wheat reduction while considering overlapping functional gastrointestinal disorders.
This lecture provides a clinically focused framework for distinguishing celiac disease from non-celiac gluten sensitivity or non-celiac wheat sensitivity, clarifying diagnostic criteria, pathophysiologic differences, and evidence-based management strategies to support accurate diagnosis and optimal patient care.
At the end of this learning activity, participants should be able to:
Dr Patrick Michael L. Roslyn, MD, FPCP
Diplomate in Gastroenterology and Digestive Endoscopy